Erkrankungen der Lebergefäße und Durchblutungsstörungen

  • Henryk Dancygier


Erkrankungen der Lebergefäße können primär, als eigenständige Krankheiten oder sekundär, im Rahmen anderer pathologischer Prozesse, auftreten. Durchblutungsstörungen der Leber manifestieren sich als Zufluss-, Durchfluss- oder Abflussstörungen, wobei eine scharfe Trennung nicht immer möglich ist.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andrade ZA, Cheever AW (1971) Alterations of the intrahepatic vasculature in hepatosplenic schistosomiasis Mansoni. Am J Trop Med Hyg 20: 425–432PubMedGoogle Scholar
  2. Bayraktar Y, Balkanci F, Bayraktar M et al. (1997) Budd-Chiari syndrome: a common complication of Behcet’s disease. Am J Gastroenterol 92: 858–862PubMedGoogle Scholar
  3. Bolondi L, Gaiani S, Bassi SL et al. (1991) Diagnosis of Budd-Chiari syndrome by pulsed Doppler sonography. Gastroenterology 100: 1324–1331PubMedGoogle Scholar
  4. Bolt RJ (1985) Diseases of the hepatic blood vessels. In: Haubrich WS, Kaiser MH, Roth TL, Schaffner F (eds), Bockus gastroenterology, 4th ed. Saunders, Philadelphia, pp 3259–3301Google Scholar
  5. Braden B, Helm B, Fabian T et al. (2000) Bazilläre Angiomatose der Leber, eine sonographische Verdachtsdiagnose? Z Gastroenterol 38: 785–789PubMedCrossRefGoogle Scholar
  6. Bras G, Jelliffe DB, Stuart KL (1954) Veno-occlusive disease of liver with non-portal type of cirrhosis occurring in Jamaica. Arch Pathol 57: 285–300Google Scholar
  7. Bruguera M, Aranguibel F, Ros E et al. (1978) Incidence and clinical significance of sinusoidal dilatation in liver biopsies. Gastroenterology 75: 474–478PubMedGoogle Scholar
  8. Campbell DA Jr, Rolles K, Jamieson N et al. (1988) Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 166: 11–18Google Scholar
  9. Chamouard P, Pencreach E, Maloisel F et al. (1999) Frequent factor II G20210 A mutation in idiopathic portal vein thrombosis. Gastroenterology 116: 144–148PubMedCrossRefGoogle Scholar
  10. Chiari H (1899) Über die selbständige Phlebitis obliterans der Hauptstämme der Vv. hepaticae als Todesursache. Beitr Z Pathol Anat 26: 1–18Google Scholar
  11. Chopra S, Rubinow A, Koff RS et al. (1984) Hepatic amyloidosis. A histopathologic analysis of primary (AL) and seeondary (AA) forms. Am J Pathol 115: 186–193PubMedGoogle Scholar
  12. Condat B, Pessione F, Denninger MH et al. (2000) Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on antiecagulant therapy. Hepatology 32: 466–470PubMedCrossRefGoogle Scholar
  13. Condat B, Pessione F, Hillaire S et al. (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of antiecagulant therapy. Gastroenterology 120: 490–497PubMedCrossRefGoogle Scholar
  14. Datta DV, Mitra SK, Chuttani PN et al. (1979) Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (noncirrhotic potal fibrosis) in India. Gut 20: 378–384PubMedCrossRefGoogle Scholar
  15. Denninger MH, Chait Y, Casadevall N et al. (2000) Cause of portal or Hepatic venous thrombosis in adults: role of multiple concurring factors. Hepatology 31: 587–591PubMedCrossRefGoogle Scholar
  16. Dilawari JB, Bambery P, Chawla Y et al. (1994) Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 73: 21–36Google Scholar
  17. Espinosa G, Font J, Garda-Pagan JC et al. (2001) Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristiec of 43 patients. Medicine (Baltimore) 80: 345–354CrossRefGoogle Scholar
  18. Faust TW (1999) Budd-Chiari syndrome. Curr Treat Opt Gastroenterol 2: 491–504CrossRefGoogle Scholar
  19. Fisher NC, MeCafferty I, Dolapci M et al. (1999) Managing Budd-Chiari syndrome: a retrospective review of pereutaneous Hepatic vein angioplasty and surgical shunting. Gut 44: 568–574PubMedCrossRefGoogle Scholar
  20. Ganguli SC, Ramzan NN, MeKusick MA et al. (1998) Budd-Chiari syndrome in patients with hematological disease: a therapeutic challenge. Hepatology 27: 1157–1161PubMedCrossRefGoogle Scholar
  21. Kohli P, Pande GK, Dev V et al. (1993) Management of Hepatic venous outflow obstruction. Lancet 342: 718–722PubMedCrossRefGoogle Scholar
  22. Ludwig J, Wiesner RH, Batts KP (1987) The acute vanishing bile duet syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7: 476–483PubMedCrossRefGoogle Scholar
  23. Ludwig J, Hashimoto E, McGill DB et al. (1990) Classification of Hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 65: 51–55PubMedGoogle Scholar
  24. Mahmoud AEA, Helmy AS, Billingham L et al. (1997) Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol 9: 485–489PubMedGoogle Scholar
  25. Moore EH, Russell LA, Klein JS et al. (1995) Bacillary angiomatosis in patients with AIDS: multiorgan imaging findings. Radiology 197: 67–72PubMedGoogle Scholar
  26. Morris JS, Schmid M, Newman S et al. (1974) Arsenic and non-cirrhotic portal hypertension. Gastroenterology 64: 86–94Google Scholar
  27. Ochs A, Sellinger M, Haag K et al. (1993) Transjugular intrahepatic porto-systemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18: 217–225PubMedCrossRefGoogle Scholar
  28. Okuda K, Omata M (1983) Idiopathic portal hypertension. University of Tokyo Press, pp 1-606Google Scholar
  29. Paradinas FJ, Bull TB, Westaby D et al. (1977) Hyperplasia and prolapse of hepatocytes into hepatic veins during long-term methyltestosterone therapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours. Histopathology 1: 225–246PubMedCrossRefGoogle Scholar
  30. Singh V, Sinha SK, Nain CK et al. (2000) Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 15:550–554CrossRefGoogle Scholar
  31. Tilanus HW (1995) Budd-Chiari syndrome. Br J Surg 82: 1023–1030PubMedCrossRefGoogle Scholar
  32. Vauthey JN, Tomczak RJ, Helmberger T et al. (1997) The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology 113: 1390–1401PubMedCrossRefGoogle Scholar
  33. Wang ZG, Jones RS (1996) Budd-Chiari syndrome. Curr Probl Surg 33: 83–211PubMedCrossRefGoogle Scholar
  34. Wanless IR, Das A, Boitnott JK et al. (1990) Hepatic vascular disease and portal hypertension in polyeythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 12: 1166–1174PubMedCrossRefGoogle Scholar
  35. Winkler K, Poulsen H (1975) Liver disease with periportal sinusoidal dilatation: a possible complication to contraceptive steroids. Scand J Gastroenterol 10: 699–704PubMedGoogle Scholar
  36. Zeitoun G, Escolano S, Hadengue A et al. (1999) Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30: 84–89PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Henryk Dancygier
    • 1
  1. 1.Medizinische Klinik II, Klinikum OffenbachAkademisches Lehrkrankenhaus der Johann Wolfgang Goethe-UniversitätOffenbachDeutschland

Personalised recommendations